Tenth Bulfone-Paus retraction notice appears, in Journal of Biological Chemistry

The tenth of 12 promised retractions by Silvia Bulfone-Paus and colleagues has appeared, in the Journal of Biological Chemistry (JBC).

The paper, “Reverse signaling through membrane-bound Interleukin-15,” was published in 2004 and has been cited 31 times, according to Thomson Scientific’s Web of Knowledge. The retraction notice, just like the other one for the team’s work that appeared in the JBC, was completely uninformative: Continue reading Tenth Bulfone-Paus retraction notice appears, in Journal of Biological Chemistry

Joachim Boldt retraction tally drops by one, editors say (but record’s still safe)

As the news of Joachim Boldt’s staggering number of retractions leaps from Retraction Watch into the mainstream press, the consortium of journal editors retracting his studies has backtracked ever so slightly, announcing today that one of the 89 studies for which the German anesthesiologist lacked ethics approval in fact had such sanction.

According to the now-16 (Updated 3/7/11, as it is up from 11 several days ago) editors, LÄK-RLP,  the German body investigating the ethics component of the Boldt case: Continue reading Joachim Boldt retraction tally drops by one, editors say (but record’s still safe)

Ladies and gentlemen, we have an apparent retraction record holder: Joachim Boldt, at 89

It’s official.* Joachim Boldt now holds the record for the most retractions by a single author.

As we reported the other day, a group of anesthesia journals was on the verge of revealing a list of 89 articles by Joachim Boldt that would require retraction because the German researcher had failed to receive proper approval from ethics officials for his studies. Today, the coalition issued a letter making the retractions official.

The 89 papers join an earlier retraction in October.

Of note: Continue reading Ladies and gentlemen, we have an apparent retraction record holder: Joachim Boldt, at 89

NEJM retracts Potti paper

courtesy Duke

About a month ago, the New England Journal of Medicine told us that they didn’t “have any plans” to retract a paper by Anil Potti. Apparently, they’ve changed their minds.

Today, they posted this retraction notice: Continue reading NEJM retracts Potti paper

Two more retractions for Mori make 16 — but not a record

Biochemical Journal has retracted two articles by Naoki Mori, bringing the total number of pulled papers by the Japanese cancer researcher to sixteen.

As with the previous Mori retractions, the latest ones — of papers published in 2007 and 2010 — involve unreliable images. Mori, you’ll recall, had recycled control blots from study to study over the years, and was dismissed from his academic post in August.

The 2007 paper, “Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells,” also included a frequent co-author Mariko Tomita, who has been implicated in the deception. It has been cited 15 times, according to Thomson Scientific’s Web of Knowledge. The 2010 article, “Inhibition of Akt/GSK3β signalling pathway by Legionella pneumophila is involved in induction of T-cell apoptosis,” has not yet been cited.

In each case, the retraction notice is the same: Continue reading Two more retractions for Mori make 16 — but not a record

22 papers by Joachim Boldt retracted, and 67 likely on the way

Self-plagiarism alert: A very similar version of this post is being published online in Anesthesiology News, where one of us (AM) is managing editor.

Anesthesia & Analgesia has retracted 22 papers by Joachim Boldt, the discredited German anesthesiologist whose prolific career as a researcher has unraveled with stunning rapidity — and 67 more retractions are likely on the way from 10 other titles  that have published his work.

The 22 retractions, announced Feb. 25 on the journal’s website, come less than a month after the state medical board overseeing an investigation into Boldt’s publications said that it was looking into more than 90 of his articles out of concern that he had failed to obtain proper approval from an institutional review board for the work.

The board, Landesärztekammer Rheinland-Pfalz (LÄK-RLP), investigated 102 articles. Investigators could not find evidence of adequate IRB approval for 89 papers; for the remaining, 11 had IRB approval and two did not require it, according to the A&A notice, which was signed by  editor-in-chief Steven L. Shafer: Continue reading 22 papers by Joachim Boldt retracted, and 67 likely on the way

Ninth Bulfone-Paus retraction notice appears, in Molecular and Cellular Biology

Another retraction notice for a paper published by Silvia Bulfone-Paus and colleagues has appeared, this one for a 2005 paper in Molecular and Cellular Biology.

The retraction notice is brief but to the point: Continue reading Ninth Bulfone-Paus retraction notice appears, in Molecular and Cellular Biology

Imperial College London, where Jatinder Ahluwalia did his PhD, now repeating his key experiments

We have more news about Jatinder Ahluwalia, whose career has so far been punctuated by dismissal from the University of Cambridge for faking data, and by having been found guilty of scientific misconduct at University College London. Yesterday, we reported that Ahluwalia hadn’t told Imperial College London UCL — where he earned his PhD — about being dismissed from Cambridge.

Today, we learned that Imperial College London, where he he earned his PhD, has also had concerns over Ahluwalia’s work, and is repeating some of his experiments. In a statement, a College spokesperson told Retraction Watch:  Continue reading Imperial College London, where Jatinder Ahluwalia did his PhD, now repeating his key experiments

Ahluwalia did not tell UCL he had been dismissed from Cambridge

About two weeks ago, we reported that Jatinder Ahluwalia — a scientist at the University of East London (UEL) who had been found guilty of scientific misconduct at University College London (UCL) — had been dismissed from the University of Cambridge’s graduate studies program for data fabrication. A dean at UEL told us later that week that the university was looking into the situation, and the lack of progress and communication from senior officials apparently has the faculty in an uproar. Continue reading Ahluwalia did not tell UCL he had been dismissed from Cambridge

Two more Bulfone-Paus retraction notices appear

The number of retraction notices of papers co-authored by Silvia Bulfone-Paus is up to eight.

The Journal of Leukocyte Biology, which was apparently the first to announce they had accepted a retraction, has published its notice: Continue reading Two more Bulfone-Paus retraction notices appear